Current status of optoacoustic breast imaging and future trends in clinical application: is it ready for prime time?

被引:3
作者
Ozcan, B. Bersu [1 ]
Wanniarachchi, Hashini [1 ]
Mason, Ralph P. [1 ]
Dogan, Basak E. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Dept Radiol, 5323 Harry Hines Blvd MC 8896, Dallas, TX 75390 USA
关键词
Photoacoustic techniques; Breast; Cancer; CONTRAST-ENHANCED ULTRASOUND; SHEAR-WAVE ELASTOGRAPHY; NEOADJUVANT CHEMOTHERAPY; BENIGN; MASSES; METAANALYSIS; HYPOXIA; DIFFERENTIATION; OXYGENATION; MAMMOSCOPE;
D O I
10.1007/s00330-024-10600-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Optoacoustic imaging (OAI) is an emerging field with increasing applications in patients and exploratory clinical trials for breast cancer. Optoacoustic imaging (or photoacoustic imaging) employs non-ionizing, laser light to create thermoelastic expansion in tissues and detect the resulting ultrasonic emission. By combining high optical contrast capabilities with the high spatial resolution and anatomic detail of grayscale ultrasound, OAI offers unique opportunities for visualizing biological function of tissues in vivo. Over the past decade, human breast applications of OAI, including benign/malignant mass differentiation, distinguishing cancer molecular subtype, and predicting metastatic potential, have significantly increased. We discuss the current state of optoacoustic breast imaging, as well as future opportunities and clinical application trends.Clinical relevance statementOptoacoustic imaging is a novel breast imaging technique that enables the assessment of breast cancer lesions and tumor biology without the risk of ionizing radiation exposure, intravenous contrast, or radionuclide injection.Key Points center dot Optoacoustic imaging (OAI) is a safe, non-invasive imaging technique with thriving research and high potential clinical impact.center dot OAI has been considered a complementary tool to current standard breast imaging techniques.center dot OAI combines parametric maps of molecules that absorb light and scatter acoustic waves (like hemoglobin, melanin, lipids, and water) with anatomical images, facilitating scalable and real-time molecular evaluation of tissues.Key Points center dot Optoacoustic imaging (OAI) is a safe, non-invasive imaging technique with thriving research and high potential clinical impact.center dot OAI has been considered a complementary tool to current standard breast imaging techniques.center dot OAI combines parametric maps of molecules that absorb light and scatter acoustic waves (like hemoglobin, melanin, lipids, and water) with anatomical images, facilitating scalable and real-time molecular evaluation of tissues.Key Points center dot Optoacoustic imaging (OAI) is a safe, non-invasive imaging technique with thriving research and high potential clinical impact.center dot OAI has been considered a complementary tool to current standard breast imaging techniques.center dot OAI combines parametric maps of molecules that absorb light and scatter acoustic waves (like hemoglobin, melanin, lipids, and water) with anatomical images, facilitating scalable and real-time molecular evaluation of tissues.
引用
收藏
页码:6092 / 6107
页数:16
相关论文
共 50 条
  • [31] Commentary on the GEC-ESTRO trial: is partial breast irradiation ready for prime time?
    Sato, Kazuhiko
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S109 - S112
  • [32] Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives
    Bisson, Isabelle
    Green, Emma
    Sharpe, Michaela
    Herbert, Chris
    Hyllner, Johan
    Mount, Natalie
    REGENERATIVE MEDICINE, 2015, 10 (02) : 169 - 179
  • [33] Diffusion MRI of the breast: Current status and future directions
    Iima, Mami
    Honda, Maya
    Sigmund, Eric E.
    Kishimoto, Ayami Ohno
    Kataoka, Masako
    Togashi, Kaori
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (01) : 70 - 90
  • [34] Current Status and Future Trends of Cold Atmospheric Plasma as an Oncotherapy
    Dai, Xiaofeng
    Wu, Jiale
    Lu, Lianghui
    Chen, Yuyu
    BIOMOLECULES & THERAPEUTICS, 2023, 31 (05) : 496 - 514
  • [35] Artificial intelligence in breast imaging: Current situation and clinical challenges
    You, Chao
    Shen, Yiyuan
    Sun, Shiyun
    Zhou, Jiayin
    Li, Jiawei
    Su, Guanhua
    Michalopoulou, Eleni
    Peng, Weijun
    Gu, Yajia
    Guo, Weisheng
    Cao, Heqi
    EXPLORATION, 2023, 3 (05):
  • [36] Clinical Molecular Imaging with Radiotracers: Current Status
    Graham, Michael M.
    MEDICAL PRINCIPLES AND PRACTICE, 2012, 21 (03) : 197 - 208
  • [37] Clopidogrel and CYP2C19 Testing: Ready for Clinical Prime Time?
    Hulot, Jean-Sebastien
    Hajjar, Roger
    Montalescot, Gilles
    CLINICAL CHEMISTRY, 2012, 58 (01) : 154 - 157
  • [38] Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
    Esserman, L. J.
    Alvarado, M. D.
    Howe, R. J.
    Mohan, A. J.
    Harrison, B.
    Park, C.
    O'Donoghue, C.
    Ozanne, E. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 371 - 378
  • [39] Clinical Breast Magnetic Resonance Imaging: Technique, Indications, and Future Applications
    Greenwood, Heather I.
    Freimanis, Rita I.
    Carpentier, Bianca M.
    Joe, Bonnie N.
    SEMINARS IN ULTRASOUND CT AND MRI, 2018, 39 (01) : 45 - 59
  • [40] Accelerated partial breast irradiation: Current status with a focus on clinical practice
    Miranda, Fabiana A.
    Teixeira, Lorine A. B.
    Heinzen, Rebeca N.
    de Andrade, Felipe Eduardo M.
    Hijal, Tarek
    Buchholz, Thomas A.
    Moraes, Fabio Y.
    Poortmans, Philip
    Marta, Gustavo N.
    BREAST JOURNAL, 2019, 25 (01) : 124 - 128